A Prospective, Multicenter, Open-labeled, Parallel -Controlled Clinical Study Investigating Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
A Prospective, Multicenter, Open-labeled, Parallel -controlled Clinical Study, to evaluate
the efficacy and safety of Huaier Granule for prevention of disease progression of
hepatocarcinoma after non-radical hepatectomy.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Time to significant progression after surgery
Time to significant progression after surgery, including recurrence of local tumor, intrahepatic and extrahepatic metastasis, etc; and to evaluation of postoperative survival period.
3 years
Yes
Xiaoping Chen, Professor
Principal Investigator
Huazhong University of Science and Technology
China: Food and Drug Administration
HE-201102
NCT01760616
August 2011
December 2015
Name | Location |
---|